Toronto, Ontario--(Newsfile Corp. - October 6, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company").
Jenex would like to announce the grant of stock options to directors, officers and consultants of the Company to purchase up to an aggregate of 1,500,000 common shares of the Company pursuant to the Company's share option plan. The options are exercisable for a period of five years at a price of $0.11/share.
Jenex is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at the core of Jenex's philosophy as is the belief that such outcomes should not be a privilege for only those who can afford costly procedures and treatments, The Company's breakthrough proprietary technology delivers effective, non-invasive and pain free skin care. The Jenex Corporation trades on the NEX (NEX: JEN.H). For more information visit: www.thejenexcorporation.com or www.therozap.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
The Jenex Corporation
CEO & Chairman
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact email@example.com